Chronos Archive seal
The Human Record

Frédéric Chopin

Case HR-NI020-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
March 1, 1810 – October 17, 1849
Synthetic DOB
1810-03-01
Index visit
1838-03-17 at age 28
Synthetic MRN
HR-NI020-SYN-TD

Teaching objective: Chronic cough with hemoptysis and weight loss in a 28-year-old pianist and piano teacher: chest X-ray and CT, three sputum samples for acid-fast smear, nucleic acid amplification, culture and drug susceptibility, an interferon-gamma release assay, HIV and hepatitis testing, home airborne isolation and same-day public-health reporting; the presenting problem resolved into a diagnosis of drug-susceptible cavitary pulmonary tuberculosis; an honest test of the proposed alternatives for his lifelong chest illness (sweat chloride for cystic fibrosis and a serum alpha-1 antitrypsin level), both normal; treatment with the four-month rifapentine, moxifloxacin, isoniazid, and pyrazinamide regimen by video-observed therapy under the 1834 CDC interim guidance and the ATS/CDC/IDSA guidelines, with eligibility, weight-band dosing, baseline and monitoring tests, and the 119-dose completion rule; release from isolation and return to teaching; a contact investigation led by the health department; care for moderate malnutrition; attention to low mood and the stigma he fears; and an honest record of a missed monthly symptom check.

Historical timeline

DateEventClaims
March 1, 1810Born at Żelazowa Wola; the family moved to Warsaw within months.CLM-0001, CLM-0002
1820sRecurrent cough, fever, headaches, and swollen glands in his teens.CLM-0004
1827His youngest sister died of tuberculosis.CLM-0003
November 2, 1830Left Warsaw, never to return.CLM-0005
September 1831Settled in Paris, where he earned his living mainly by teaching.CLM-0005, CLM-0006
1836An engagement made conditional on his health; met George Sand; seriously ill the following winter.CLM-0007, CLM-0008
November 8, 1838Arrived on Majorca; gravely ill at Valldemossa through the winter.CLM-0009, CLM-0010
February 1839Convalescence in Marseille, then Nohant.CLM-0011
July 1847Final parting from George Sand.CLM-0012
1840sChest pain, hemoptysis, and breathlessness later in life.CLM-0020
November 16, 1848Last concert, in London, despite frailty and fever.CLM-0013
June 22, 1849Two hemorrhages; tuberculosis diagnosed in its final stage.CLM-0014
October 17, 1849Died in Paris.CLM-0015
2003Cystic fibrosis and alpha-1 antitrypsin deficiency proposed as retrospective diagnoses.CLM-0017, CLM-0018
2014Macroscopic examination of his preserved heart.CLM-0016
2018Heart failure with cirrhosis proposed as an alternative cause of death.CLM-0019

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Fryderyk Franciszek Chopin was born in the village of Żelazowa Wola, in Mazovia, on March 1, 1810, according to his own statements and his family's; his baptismal certificate, written several weeks after the birth, gives February 22. confirmed Biography: general outline (Barbara Smoleńska-Zielińska) supports
Chopin Fryderyk: a calendar of the composer's life and the list of works supports
D His father, Mikołaj (Nicolas) Chopin, was a Frenchman from Lorraine who settled permanently in Poland and brought up his children as Poles; the family moved to Warsaw a few months after Fryderyk's birth.
Supports his Polish and French background.
confirmed Biography: general outline (Barbara Smoleńska-Zielińska) supports
Chopin Fryderyk: a calendar of the composer's life and the list of works supports
D In 1827 the youngest of the Chopin children, his sister Emilia, died of tuberculosis.
Family history of tuberculosis.
confirmed Fryderyk Chopin: routes, family supports
D A review of the documentary sources reports recurrent episodes of cough, fever, headaches, and swollen lymph nodes beginning in his teens.
Anchor for the lifelong chest illness behind the presenting problem.
probable Perciaccante A, Charlier P, Negri C, et al. Did Frédéric Chopin Die From Heart Failure? J Card Fail. 2018;24(5):342-344 supports
D He left Warsaw on November 2, 1830, never to return, reached Paris in September 1831, and in 1834 chose the status of a political refugee rather than apply to the Russian embassy for a passport.
Supports his life away from his homeland in the modern social history.
confirmed Chopin Fryderyk: a calendar of the composer's life and the list of works supports
Biography: general outline (Barbara Smoleńska-Zielińska) supports
D In Paris his most important source of income was giving lessons; he became a popular teacher, and although ranked among the greatest pianists of his time, he disliked public performances, appeared rarely, and preferred an intimate group of listeners.
Supports his modern occupation as a pianist who earns his living by teaching.
confirmed Biography: general outline (Barbara Smoleńska-Zielińska) supports
D In 1836 a proposal of marriage was accepted on condition that he take better care of his health; the engagement ended a year later, the family of his fiancée being disturbed by the bad state of his health, as he had been seriously ill in the winter.
Documented frailty and a serious winter illness before the index date.
confirmed Biography: general outline (Barbara Smoleńska-Zielińska) supports
Chopin Fryderyk: a calendar of the composer's life and the list of works supports
D He met the writer George Sand in Paris in 1836; their relationship, which began soon after, lasted nearly ten years. confirmed Fryderyk Chopin and George Sand: the trip to Majorca (Bożena Schmid-Adamczyk, Fryderyk Chopin and George Sand Museum, Valldemossa) supports
Chopin Fryderyk: a calendar of the composer's life and the list of works supports
D In the winter of 1838 to 1839 he stayed on Majorca, arriving in Palma on November 8, 1838. In early December the rented villa became cold and damp, his health worsened, and doctors were called; he wrote on December 3 that he had become "sick as a dog" over the previous two weeks. Neighbors fearing an infectious disease led the owner to force them to leave. At the former Carthusian monastery in Valldemossa, from December 15 to February 11, he became gravely ill and showed symptoms of tuberculosis, and for many weeks was too weak to leave the house, yet composed most of the 24 Preludes.
The documented crisis of his chest illness, after the index date.
confirmed Fryderyk Chopin and George Sand: the trip to Majorca (Bożena Schmid-Adamczyk, Fryderyk Chopin and George Sand Museum, Valldemossa) supports
Biography: general outline (Barbara Smoleńska-Zielińska) supports
Chopin Fryderyk: a calendar of the composer's life and the list of works supports
D On Majorca he suffered long periods of doubt and depression, associated with his illness, and the hostility of local people who feared his illness worsened his state of mind.
Low mood with illness and stigma, in the lay words of the source; not a diagnosis.
confirmed Fryderyk Chopin and George Sand: the trip to Majorca (Bożena Schmid-Adamczyk, Fryderyk Chopin and George Sand Museum, Valldemossa) supports
D After Majorca he convalesced in Marseille from late February to May 1839, cared for by a physician, and moved to Nohant in central France still greatly weakened. confirmed Fryderyk Chopin and George Sand: the trip to Majorca (Bożena Schmid-Adamczyk, Fryderyk Chopin and George Sand Museum, Valldemossa) supports
Biography: general outline (Barbara Smoleńska-Zielińska) supports
D The final parting from George Sand in July 1847 and the loss of Nohant had a devastating effect on his mental and physical state, and he almost gave up composing. confirmed Biography: general outline (Barbara Smoleńska-Zielińska) supports
Chopin Fryderyk: a calendar of the composer's life and the list of works context
D From April to November 1848 he toured England and Scotland; the travel, the many performances, and a climate harmful to his lungs further damaged his health, and on November 16, 1848, despite frailty and a fever, he gave his last concert, in London. confirmed Biography: general outline (Barbara Smoleńska-Zielińska) supports
Chopin Fryderyk: a calendar of the composer's life and the list of works supports
D In 1849, after two hemorrhages on June 22, a physician diagnosed tuberculosis in its final stage.
The documented diagnosis made in his lifetime.
confirmed Chopin Fryderyk: a calendar of the composer's life and the list of works supports
D He died on October 17, 1849, in his apartment on the Place Vendôme in Paris, of pulmonary tuberculosis according to the Fryderyk Chopin Institute, and was buried in the Père-Lachaise cemetery; at his request his heart was taken to Warsaw and placed in a pillar of the Holy Cross Church.
Recorded as a fact; the modern episode ends in cure.
confirmed Biography: general outline (Barbara Smoleńska-Zielińska) supports
Chopin Fryderyk: a calendar of the composer's life and the list of works supports
R A macroscopic examination of his preserved heart in 2014 found it enlarged and covered with a fibrinous coating with multiple small nodular foci, which the examiners interpreted as tuberculous pericarditis; they concluded that chronic tuberculosis was the most plausible diagnosis and that rapidly progressing tuberculous pericarditis was probably the immediate cause of death. An earlier review of his case history also judged tuberculosis the most probable diagnosis.
Supports the choice of pulmonary tuberculosis as the modern diagnosis; the heart was examined without tissue or microbiological testing in the cited abstracts.
probable Witt M, Szklener A, Kawecki J, et al. A Closer Look at Frederic Chopin's Cause of Death. Am J Med. 2018;131(2):211-212 supports
Witt M, Szklener A, Marchwica W, Dobosz T. Disease not genetic but infectious: multiple tuberculomas and fibrinous pericarditis as symptoms pathognomonic for tuberculosis of Frederic Chopin. J Appl Genet. 2018;59(4):471-473 supports
Witt M, Dobosz T. Inheritance vs. infectivity as a mechanism of malady and death of Frederic Chopin. J Appl Genet. 2021;62(4):607-611 supports
Young P, Bernaciak JM, Bruetman JE, Finn BC, Miranda MC. Frederic Chopin (1810-1849), and his disease. Rev Med Chil. 2014;142(4):529-35 supports
R Cystic fibrosis has been proposed as the cause of his lifelong illness and death; the roster lists a "probable cystic fibrosis variant." The heart examination's authors later argued that the disease was infectious, not genetic.
Unproven alternative; addressed in the modern episode with a sweat chloride test and not adopted.
disputed Majka L, Goździk J, Witt M. Cystic fibrosis: a probable cause of Frédéric Chopin's suffering and death. J Appl Genet. 2003;44(1):77-84 supports
Witt M, Szklener A, Marchwica W, Dobosz T. Disease not genetic but infectious: multiple tuberculomas and fibrinous pericarditis as symptoms pathognomonic for tuberculosis of Frederic Chopin. J Appl Genet. 2018;59(4):471-473 disputes
HISTMED Master Roster v3 context
R Alpha-1 antitrypsin deficiency has also been proposed, while noting that the lost autopsy record makes any diagnosis hard to confirm.
Unproven alternative; addressed in the modern episode with a serum alpha-1 antitrypsin level and not adopted.
disputed Eriksson S. Did Chopin suffer of antitrypsin deficiency? Lost autopsy protocol has caused frustration among physicians of our time in their attempts to confirm the diagnosis. Lakartidningen. 2003;100(30-31):2449-54 supports
Witt M, Szklener A, Marchwica W, Dobosz T. Disease not genetic but infectious: multiple tuberculomas and fibrinous pericarditis as symptoms pathognomonic for tuberculosis of Frederic Chopin. J Appl Genet. 2018;59(4):471-473 disputes
Young P, Bernaciak JM, Bruetman JE, Finn BC, Miranda MC. Frederic Chopin (1810-1849), and his disease. Rev Med Chil. 2014;142(4):529-35 context
D The same review reports that later in life he had chest pain, hemoptysis, hematemesis, neuralgia, and joint pain, and that exhaustion and breathlessness characterized all his adult life.
Anchor for the hemoptysis and frailty of the presenting illness; the dated hemoptysis comes after the index date.
probable Perciaccante A, Charlier P, Negri C, et al. Did Frédéric Chopin Die From Heart Failure? J Card Fail. 2018;24(5):342-344 supports
R Another documentary review proposed that he had dilated cardiomyopathy with heart failure and cirrhosis, rather than tuberculosis, as the cause of death.
Alternative interpretation recorded for completeness; not used.
disputed Perciaccante A, Charlier P, Negri C, et al. Did Frédéric Chopin Die From Heart Failure? J Card Fail. 2018;24(5):342-344 supports
Witt M, Dobosz T. Inheritance vs. infectivity as a mechanism of malady and death of Frederic Chopin. J Appl Genet. 2021;62(4):607-611 disputes

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Cough for about three months, blood-streaked sputum for two weeks, night sweats, and weight loss of about 6 kg in a man of 28, with a right upper lobe cavity on chest X-ray and CT: suspected pulmonary tuberculosis; home airborne isolation and three sputum samples for acid-fast smear, nucleic acid amplification, and culture resolved confirmed active CLM-0004, CLM-0020
S Pulmonary tuberculosis of the right upper lobe, cavitary and sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistance active confirmed both_with_link CLM-0004, CLM-0014, CLM-0016
S Moderate protein-calorie malnutrition: BMI 16.8, about 11 percent weight loss in three months, and albumin 3.2 g/dL resolved confirmed active CLM-0004, CLM-0007
S Acute viral upper respiratory infection during the continuation phase of tuberculosis treatment; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1838-03-17 Hemoglobin [Mass/volume] in Blood 12.1 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1838-03-17 Leukocytes [#/volume] in Blood by Automated count 9.6 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1838-03-17 Platelets [#/volume] in Blood by Automated count 442 10*3/uL (high)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1838-03-17 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 1838-03-17 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 1838-03-17 Bilirubin.total [Mass/volume] in Serum or Plasma 0.5 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1838-03-17 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 84 U/L
Reference 40-129 U/L
http://loinc.org · 6768-6
S 1838-03-17 Albumin [Mass/volume] in Serum or Plasma 3.2 g/dL (low)
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 1838-03-17 Creatinine [Mass/volume] in Serum or Plasma 0.78 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1838-03-17 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1833)/1.73 sq M 125 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1838-03-17 Glucose [Mass/volume] in Serum or Plasma 86 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1838-03-17 Potassium [Moles/volume] in Serum or Plasma 4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1838-03-17 Calcium [Mass/volume] in Serum or Plasma 9 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1838-03-17 Magnesium [Mass/volume] in Serum or Plasma 2 mg/dL
Reference 1.7-2.2 mg/dL
http://loinc.org · 19123-9
S 1838-03-17 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 1838-03-17 Total score [AUDIT-C] 2 http://loinc.org · 75626-2
S 1838-04-07 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 34 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 1838-04-07 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 1838-04-07 Bilirubin.total [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1838-04-07 Chloride [Moles/volume] in Sweat 18 mmol/L
Reference <=29 mmol/L
http://loinc.org · 2077-6
S 1838-04-07 Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Nephelometry 142 mg/dL
Reference 100-190 mg/dL
http://loinc.org · 6771-0
S 1838-05-15 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 29 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 1838-05-15 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 1838-05-15 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1838-05-15 Hemoglobin [Mass/volume] in Blood 13 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1838-05-15 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 1838-07-21 Hemoglobin [Mass/volume] in Blood 14.1 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1838-07-21 Albumin [Mass/volume] in Serum or Plasma 4 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 1838-07-21 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 1838-07-21 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 1838-09-15 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1838-09-15 Total score [AUDIT-C] 2 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
1838-03-17Body height170 cm8302-2S
1838-03-17Body weight48.5 kg29463-7S
1838-03-17Body mass index (BMI) [Ratio]16.8 kg/m239156-5S
1838-03-17Systolic blood pressure104 mm[Hg]8480-6S
1838-03-17Diastolic blood pressure66 mm[Hg]8462-4S
1838-03-17Heart rate102 /min8867-4S
1838-03-17Respiratory rate20 /min9279-1S
1838-03-17Body temperature37.9 Cel8310-5S
1838-03-17Oxygen saturation in Arterial blood by Pulse oximetry95 %59408-5S
1838-03-20Body height170 cm8302-2S
1838-03-20Body weight48.4 kg29463-7S
1838-03-20Body mass index (BMI) [Ratio]16.7 kg/m239156-5S
1838-03-20Systolic blood pressure102 mm[Hg]8480-6S
1838-03-20Diastolic blood pressure64 mm[Hg]8462-4S
1838-03-20Heart rate98 /min8867-4S
1838-03-20Respiratory rate18 /min9279-1S
1838-03-20Body temperature37.6 Cel8310-5S
1838-03-20Oxygen saturation in Arterial blood by Pulse oximetry95 %59408-5S
1838-04-07Body height170 cm8302-2S
1838-04-07Body weight49.6 kg29463-7S
1838-04-07Body mass index (BMI) [Ratio]17.2 kg/m239156-5S
1838-04-07Systolic blood pressure106 mm[Hg]8480-6S
1838-04-07Diastolic blood pressure66 mm[Hg]8462-4S
1838-04-07Heart rate86 /min8867-4S
1838-04-07Respiratory rate16 /min9279-1S
1838-04-07Body temperature37 Cel8310-5S
1838-04-07Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1838-05-15Body height170 cm8302-2S
1838-05-15Body weight52 kg29463-7S
1838-05-15Body mass index (BMI) [Ratio]18 kg/m239156-5S
1838-05-15Systolic blood pressure108 mm[Hg]8480-6S
1838-05-15Diastolic blood pressure68 mm[Hg]8462-4S
1838-05-15Heart rate78 /min8867-4S
1838-05-15Respiratory rate16 /min9279-1S
1838-05-15Body temperature36.8 Cel8310-5S
1838-05-15Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1838-07-21Body height170 cm8302-2S
1838-07-21Body weight55 kg29463-7S
1838-07-21Body mass index (BMI) [Ratio]19 kg/m239156-5S
1838-07-21Systolic blood pressure110 mm[Hg]8480-6S
1838-07-21Diastolic blood pressure70 mm[Hg]8462-4S
1838-07-21Heart rate72 /min8867-4S
1838-07-21Respiratory rate14 /min9279-1S
1838-07-21Body temperature36.6 Cel8310-5S
1838-07-21Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1838-06-09Body height170 cm8302-2S
1838-06-09Body weight53.6 kg29463-7S
1838-06-09Body mass index (BMI) [Ratio]18.5 kg/m239156-5S
1838-06-09Systolic blood pressure108 mm[Hg]8480-6S
1838-06-09Diastolic blood pressure68 mm[Hg]8462-4S
1838-06-09Heart rate88 /min8867-4S
1838-06-09Respiratory rate16 /min9279-1S
1838-06-09Body temperature37.6 Cel8310-5S
1838-06-09Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1838-09-15Body height170 cm8302-2S
1838-09-15Body weight56.2 kg29463-7S
1838-09-15Body mass index (BMI) [Ratio]19.4 kg/m239156-5S
1838-09-15Systolic blood pressure112 mm[Hg]8480-6S
1838-09-15Diastolic blood pressure70 mm[Hg]8462-4S
1838-09-15Heart rate70 /min8867-4S
1838-09-15Respiratory rate14 /min9279-1S
1838-09-15Body temperature36.6 Cel8310-5S
1838-09-15Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Complete all 119 doses within five months by video-observed therapy1838-07-21completedAll 119 doses completed in 17 weeks: 56 in the intensive phase and 63 in the continuation phase, with none missed
Sputum culture negative at two months1838-07-21completedThe two-month culture showed no growth, as did the cultures from the third week
Return to teaching once the health department confirms he is no longer infectious1838-04-07completedReleased from isolation after three negative smears and more than two weeks of treatment; teaching again from the third week
Weight back to at least 55 kg by the end of treatment1838-07-21completed55.0 kg at the end of treatment, from 48.5 kg at diagnosis
PHQ-9 below 5 by the end of treatment1838-07-21completedPHQ-9 3 at the end of treatment, from 7 at diagnosis

Interventions

InterventionStatusGuideline
Infectious diseases consultation to confirm the diagnosis, choose between the six-month and four-month regimens, plan monitoring and his return to teaching, and address cystic fibrosis and alpha-1 antitrypsin deficiency as explanations for his lifelong chest illnesscompletedGL-ATS-TB-2016, GL-CDC-4MO-2022
Diagnosis: three sputum samples at least eight hours apart, one early in the morning, for acid-fast smear, nucleic acid amplification with rifampin resistance, culture, molecular testing for isoniazid and fluoroquinolone resistance, and phenotypic susceptibility; an interferon-gamma release assay; HIV, hepatitis B, and hepatitis C tests; and baseline blood count, liver and kidney tests, potassium, calcium, and magnesiumcompletedGL-ATS-TB-2016, GL-CDC-4MO-2022
Infection control and public health: home airborne isolation with no students or visitors and a surgical mask around others; same-day report of suspected tuberculosis to the health department; a contact investigation of his students, friends, and other close contacts led by the health departmentcompletedGL-CDC-CONTACT-2005, GL-ATS-TB-2016
Nutrition: two dietitian visits in the first month, three meals and three energy-dense snacks a day, two oral nutrition supplement drinks a day, and weight at every visitcompletedGL-ASPEN-MALN-2012, GL-ATS-TB-2016
Support: plain information about how tuberculosis spreads, how quickly treatment makes him non-infectious, and that it is curable; help with what to tell his students; PHQ-9 at diagnosis, at two months, and at the end of treatmentcompletedGL-USPSTF-DEP-2023, GL-ATS-TB-2016
Treatment: the four-month regimen of rifapentine 1200 mg, moxifloxacin 400 mg, isoniazid 300 mg, and pyrazinamide 1000 mg daily with food for eight weeks, then rifapentine, moxifloxacin, and isoniazid for nine weeks, with pyridoxine, by video-observed therapy seven days a week; complete when 119 doses are taken within five monthscompletedGL-CDC-4MO-2022, GL-ATS-TB-2025, GL-ATS-TB-2016
Monitoring: symptoms, weight, adverse effects (liver, tendons, nerves) and observed doses at every visit; liver tests at two to three weeks and for symptoms; sputum smears in the third week for release, then monthly culture until two are negative, including the two-month culture; phenotypic susceptibility including moxifloxacin; PHQ-9 at two months and at the endcompletedGL-CDC-4MO-2022, GL-ATS-HEPATOTOX-2006
Sweat chloride test and serum alpha-1 antitrypsin level once he is out of isolation, to address cystic fibrosis and alpha-1 antitrypsin deficiency as the proposed alternativescompletedGL-CFF-DX-2017, GL-ATS-A1AT-2003

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Biography: general outline (Barbara Smoleńska-Zielińska) The Fryderyk Chopin Institute (chopin.pl) biography
SRC-0002 Chopin Fryderyk: a calendar of the composer's life and the list of works Polish Music Information Centre (POLMIC), Polish Composers' Union biography
SRC-0003 Fryderyk Chopin and George Sand: the trip to Majorca (Bożena Schmid-Adamczyk, Fryderyk Chopin and George Sand Museum, Valldemossa) The Fryderyk Chopin Institute (chopin.pl) biography
SRC-0004 Fryderyk Chopin: routes, family Narodowy Instytut Fryderyka Chopina (Great Composers) biography
SRC-0005 Witt M, Szklener A, Kawecki J, et al. A Closer Look at Frederic Chopin's Cause of Death. Am J Med. 2018;131(2):211-212 American Journal of Medicine (PubMed 29031593) scholarly
SRC-0006 Witt M, Szklener A, Marchwica W, Dobosz T. Disease not genetic but infectious: multiple tuberculomas and fibrinous pericarditis as symptoms pathognomonic for tuberculosis of Frederic Chopin. J Appl Genet. 2018;59(4):471-473 Journal of Applied Genetics (PubMed 30047032) scholarly
SRC-0007 Witt M, Dobosz T. Inheritance vs. infectivity as a mechanism of malady and death of Frederic Chopin. J Appl Genet. 2021;62(4):607-611 Journal of Applied Genetics (PubMed 34347238) scholarly
SRC-0008 Majka L, Goździk J, Witt M. Cystic fibrosis: a probable cause of Frédéric Chopin's suffering and death. J Appl Genet. 2003;44(1):77-84 Journal of Applied Genetics (PubMed 12590184) scholarly
SRC-0009 Eriksson S. Did Chopin suffer of antitrypsin deficiency? Lost autopsy protocol has caused frustration among physicians of our time in their attempts to confirm the diagnosis. Lakartidningen. 2003;100(30-31):2449-54 Läkartidningen (PubMed 12914142) scholarly
SRC-0010 Perciaccante A, Charlier P, Negri C, et al. Did Frédéric Chopin Die From Heart Failure? J Card Fail. 2018;24(5):342-344 Journal of Cardiac Failure (PubMed 29597050) scholarly
SRC-0011 Young P, Bernaciak JM, Bruetman JE, Finn BC, Miranda MC. Frederic Chopin (1810-1849), and his disease. Rev Med Chil. 2014;142(4):529-35 Revista Médica de Chile (PubMed 25117047) scholarly
SRC-0012 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review.
provenance reviewnot_startedBiography from the Fryderyk Chopin Institute, the Polish Music Information Centre, and the Valldemossa museum page; retrospective diagnoses from PubMed records. The birth-date conflict (March 1 or February 22, 1810) is recorded. Tuberculosis is graded D as diagnosed in his lifetime and R (probable) for the 2014 heart examination; cystic fibrosis, alpha-1 antitrypsin deficiency, and heart failure are R and disputed.
safe messaging reviewnot_startedThe two claims about low mood are marked sensitive and quoted in the source's lay words, not as diagnoses. PHQ-9 at most 7 and no F-code, so no safety assessment is required; item 9 is recorded at each PHQ-9. George Sand appears only in documented history claims; contacts in the investigation are synthetic and unnamed, and no result is attributed to anyone.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.